Your session is about to expire
← Back to Search
Gene Therapy
30 mg dose of JVS-100 for Heart Failure (RETRO-HF Trial)
Phase 1 & 2
Waitlist Available
Research Sponsored by Juventas Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
ASA unless contraindicated
Willing and able to sign informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 and/or 12 months
Awards & highlights
RETRO-HF Trial Summary
A phase I/II study to evaluate the safety and efficacy of JVS-100 administered by retrograde delivery to cohorts of adults with Ischemic Heart Failure.
Eligible Conditions
- Heart Failure
RETRO-HF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRETRO-HF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 and/or 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 and/or 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Impact of JVS-100 delivery on 6 minute walk distance at 4 month follow-up
Secondary outcome measures
Impact of JVS-100 delivery on heart failure symptoms compared to placebo at 4 and/or 12 month follow-up
Other outcome measures
Impact of JVS-100 delivery on quality of life measure at 4 month follow-up
RETRO-HF Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: 45 mg dose of JVS-100Experimental Treatment2 Interventions
Group II: 30 mg dose of JVS-100Experimental Treatment2 Interventions
Group III: PlaceboPlacebo Group2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
Find a Location
Who is running the clinical trial?
Juventas Therapeutics, Inc.Lead Sponsor
5 Previous Clinical Trials
440 Total Patients Enrolled
3 Trials studying Heart Failure
272 Patients Enrolled for Heart Failure
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger